Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureShigeyoshi Itohara, Toshiaki Nakashiba
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
2013
The attention system of the human brain: 20 years after
10.1146/annurev-neuro-062111-150525 · 2012
Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review
10.1038/npp.2009.185 · 2010
Adolescent impulsivity phenotypes characterized by distinct brain networks
10.1038/nn.3092 · 2012
The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis
10.1111/j.1469-7610.2006.01671.x · 2006
Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder
10.1016/j.biopsych.2006.06.011 · 2007
ADHD and personality: a meta-analytic review
10.1016/j.cpr.2014.05.002 · 2014
Functional deficits of the attentional networks in autism
10.1002/brb3.90 · 2012
Sustained attention deficit in bipolar disorder
10.1192/bjp.180.4.313 · 2002
Procedural skills and neurobehavioral freedom
2014
Molecular genetics of attention-deficit/hyperactivity disorder
10.1016/j.biopsych.2004.11.024 · 2005
Association of attention-deficit disorder and the dopamine transporter gene
1995
Candidate gene studies of ADHD: a meta-analytic review
10.1007/s00439-009-0694-x · 2009
Role of dopamine receptors in ADHD: a systematic meta-analysis
10.1007/s12035-012-8278-5 · 2012
Genome-wide association studies in ADHD
10.1007/s00439-009-0663-4 · 2009
Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder
10.1038/ng.1013 · 2012
Overview of animal models of attention deficit hyperactivity disorder (ADHD)
2011
Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity
10.1126/science.283.5400.397 · 1999
Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists
10.1523/jneurosci.21-01-00305.2001 · 2001
Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice
10.1038/sj.npp.1301009 · 2006
Impaired cliff avoidance reaction in dopamine transporter knockout mice
10.1007/s00213-013-3009-9 · 2013
Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania
10.1177/0269881111400646 · 2011
Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter
10.1073/pnas.0600905103 · 2006
Amphetamine-induced locomotion in a hyperdopaminergic ADHD mouse model depends on genetic background
10.1016/j.pbb.2012.09.020 · 2013
Transgenic mouse models for ADHD
10.1007/s00441-013-1639-1 · 2013
The effect of reduced dopamine D4 receptor expression in the 5-choice continuous performance task: Separating response inhibition from premature responding
10.1016/j.bbr.2011.03.054 · 2011
The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry
10.1007/s00213-002-1154-7 · 2002
The 5-choice continuous performance test: evidence for a translational test of vigilance for mice
10.1371/journal.pone.0004227 · 2009
Effects of sex COMT genotype on environmentally modulated cognitive control in F mice
10.1073/pnas.1214397109 · 2012
Epistatic interaction between COMT and DTNBP1 modulates prefrontal function in mice and in humans
10.1038/mp.2013.133 · 2014
The schizophrenia susceptibility gene dysbindin controls synaptic homeostasis
10.1126/science.1179685 · 2009
Role for the membrane receptor guanylyl cyclase-C in attention deficiency and hyperactive behavior
10.1126/science.1207675 · 2011
Association between polymorphisms in serotonin 2C receptor gene and attention-deficit/hyperactivity disorder in Han Chinese subjects
10.1016/j.neulet.2006.08.022 · 2006
Investigation of the serotonin 2C receptor gene in attention deficit hyperactivity disorder in UK samples
10.1186/1756-0500-2-71 · 2009
Impact of serotonin (5-HT)2C receptors on executive control processes
10.1038/npp.2012.258 · 2013
Involvement of the prefrontal cortex but not the dorsal hippocampus in the attention-enhancing effects of nicotine in rats
10.1007/s00213-003-1438-6 · 2003
Why do young women smoke? V. Role of direct and interactive effects of nicotinic cholinergic receptor gene variation on neurocognitive function
10.1111/j.1601-183x.2007.00329.x · 2008
Nicotinic acetylcholine receptor beta2 subunits in the medial prefrontal cortex control attention
10.1126/science.1207079 · 2011
The nicotinic acetylcholine receptor alpha5 subunit plays a key role in attention circuitry and accuracy
10.1523/jneurosci.2258-10.2010 · 2010
Plasticity of prefrontal attention circuitry: upregulated muscarinic excitability in response to decreased nicotinic signaling following deletion of alpha5 or beta2 subunits
10.1523/jneurosci.3600-11.2011 · 2011
Neuregulin 3 is associated with attention deficits in schizophrenia and bipolar disorder
10.1017/s1461145712000697 · doi-reference
Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds activates ErbB4
10.1073/pnas.94.18.9562 · doi-reference
Neuregulin-3 in the mouse medial prefrontal cortex regulates impulsive action
10.1016/j.biopsych.2014.02.011 · doi-reference
Independent genetic loci for sensorimotor gating and attentional performance in BXD recombinant inbred strains
10.1111/j.1601-183x.2011.00754.x · doi-reference
Genetic and pharmacological modulation of the steroid sulfatase axis improves response control; comparison with drugs used in ADHD
10.1038/npp.2014.115 · doi-reference
A novel translational assay of response inhibition and impulsivity: effects of prefrontal cortex lesions, drugs used in ADHD, and serotonin 2C receptor antagonism
10.1038/npp.2013.112 · doi-reference
Converging pharmacological and genetic evidence indicates a role for steroid sulfatase in attention
10.1016/j.biopsych.2009.01.001 · doi-reference
Biological mechanisms associated with increased perseveration and hyperactivity in a genetic mouse model of neurodevelopmental disorder
10.1016/j.psyneuen.2012.12.002 · doi-reference
Gamma aminobutyric acid transporter subtype 1 gene knockout mice: a new model for attention deficit/hyperactivity disorder
10.1093/abbs/gmt043 · doi-reference
GABA transporter-1 (GAT1)-deficient mice: differential tonic activation of GABAA versus GABAB receptors in the hippocampus
10.1152/jn.00240.2003 · doi-reference
Neurofibromin regulation of ERK signaling modulates GABA release and learning
10.1016/j.cell.2008.09.060 · doi-reference
The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1
10.1016/j.cub.2005.09.043 · doi-reference
The association of neurofibromatosis type 1 and attention deficit hyperactivity disorder
10.1076/chin.6.3.185.3155 · doi-reference
Modeling hyperactivity: of mice and men
10.1038/nm0511-541 · doi-reference
Association study of GIT1 gene with attention-deficit hyperactivity disorder in Brazilian children and adolescents
10.1111/j.1601-183x.2012.00835.x · doi-reference
GIT1 is associated with ADHD in humans and ADHD-like behaviors in mice
10.1038/nm.2330 · doi-reference
The multifunctional GIT family of proteins
10.1242/jcs.02925 · doi-reference
beta2-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein
10.1073/pnas.95.24.14082 · doi-reference
Attention-Deficit/Hyperactivity Disorder-like Phenotype in a Mouse Model with Impaired Actin Dynamics
10.1016/j.biopsych.2014.03.011 · doi-reference
Structural plasticity of dendritic spines
10.1016/j.conb.2011.09.002 · doi-reference
Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy
10.1038/nrn2373 · doi-reference
A.C. Gray, and R.D. Burwell, Discrimination learning and attentional set formation in a mouse model of Fragile X
10.1037/a0023561 · doi-reference
Hyperactivity, perseveration and increased responding during attentional rule acquisition in the Fragile X mouse model
10.3389/fnbeh.2013.00172 · doi-reference
Attentional dysfunction, impulsivity, and resistance to change in a mouse model of fragile X syndrome
10.1037/0735-7044.120.6.1367 · doi-reference
Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome
10.1038/nn.3033 · doi-reference
Treatment with valproic acid ameliorates A.D.H.D. symptoms in fragile X. syndrome boys
10.1002/ajmg.a.33484 · doi-reference
Toward fulfilling the promise of molecular medicine in fragile X syndrome
10.1146/annurev-med-061109-134644 · doi-reference
Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD
10.1176/appi.ajp.2011.11040551 · doi-reference
Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice
10.1016/j.euroneuro.2006.03.008 · doi-reference
Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task
10.1007/s00213-006-0549-2 · doi-reference